efficacy of secukinumab in moderate-to-severe psoriasis | pharmaceuticals 2022
Published 1 year ago • 76 plays • Length 14:29Download video MP4
Download video MP3
Similar videos
-
3:58
secukinumab is effective in moderate to severe plaque psoriasis when compared to ustekinumab
-
6:01
efficacy and safety of secukinumab in psoriasis over 5 years, r. langley et al.
-
3:55
secukinumab in moderate-to-severe plaque psoriasis, k. reich et al
-
3:20
flexible dosing of secukinumab in patients with psoriasis weighing ≥90 kg, m. augustin et al
-
2:56
secukinumab vs. fumaric acid esters in plaque psoriasis, m. sticherling et al.
-
6:12
superior risankizumab efficacy vs. apremilast in systemic-eligible moderate psoriasis.
-
3:39
long-term efficacy of secukinumab in palmoplantar psoriasis, a.b. gottlieb et al
-
3:10
secukinumab individualized dosing in chronic plaque psoriasis, k. reich et al
-
4:29
biologic drug survival in psoriasis, z.z.n. yiu et al.
-
3:52
expert commentary: the exceed trial | laura coates
-
1:29
prevalence of psoriasis
-
34:56
clinical assessment and principles of management of psoriasis
-
5:13
sustained efficacy in nail psoriasis with secukinumab treatment, k. reich et al
-
8:03
comparative efficacy of biologic & oral agents in palmoplantar psoriasis & palmoplantar pustulosis
-
![secukinumab [thu0325] ( part 1) - psoriatic arthritis posters and abstracts from amsterdam](https://i.ytimg.com/vi/ZmxJCdntK4o/mqdefault.jpg)
6:16
secukinumab [thu0325] ( part 1) - psoriatic arthritis posters and abstracts from amsterdam
-
3:12
how cosentyx (secukinumab) works in plaque psoriasis
-
55:17
expanding treatment options for youth with psoriasis
-
1:29
horizon program provides treatment recommendations for patients with moderate to severe psoriasis 1
-
26:48
psa podcast: guselkumab & secukinumab – all the latest in efficacy & safety